Market Tracker

04/01 5:16pm ET

SPDR® S&P Biotech ETF (XBI)

During the Trading Day
220.79 -4.71 / -2.09%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
220.38 -0.41 / -0.19%
Volume: 2.4K

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+2.91% 3 years+40.79%
3 months+18.46% 5 years+30.22%
1 year+56.62% Since inception+18.13%
Data through 04/01/2015

Quote Details

Previous close$225.50
Open day’s range214.74 – 222.24
Net asset value (NAV)220.57 (03/31/2015)
Daily volume1,516,435
Average volume (3 months)814,175
Data as of 3:59pm ET, 04/01/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+30.22%+22.29%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio1.221.51
Net assets$2.1B$1.7B
Average market cap$2.3B$32.9B
Average P/E--26.3
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
EXEL Exelixis Inc2.18%
FMI Foundation Medicine Inc2.11%
HALO Halozyme Therapeutics Inc1.96%
NBIX Neurocrine Biosciences Inc1.85%
OPK OPKO Health Inc1.85%
PCYC Pharmacyclics Inc1.69%
ICPT Intercept Pharmaceuticals Inc1.67%
NVAX Novavax Inc1.65%
XON Intrexon Corp1.58%